Covid-19 vaccines roll out in India

India has the second-largest manufacturing capability to produce vaccines

India has the second-largest capability globally, to manufacture Covid-19 vaccines. Chart from Statista
India has the second-largest capability globally, to manufacture Covid-19 vaccines. Chart from Statista

The morning dailies in India are full of headlines and photos showing the shipments of Covid-19 vaccines rolling out to airports and major cities in a transport cold chain that includes planes and trucks. From the major cities, these will go to smaller towns and centers. The designated hospitals and vaccination centers will start vaccinating front line workers and healthcare staff in the first phase of 3 crore (30 million) vaccinations.

Pune’s Serum Institute of India sent its batches of Covishield (the Oxford-Astrazeneca vaccine) out on Tuesday morning – 12 January 2020. In its 148-page document, the Health and Family Welfare ministry has spelled out the operational guidelines, and the preparations at the hospitals and vaccination centers are mostly in line with these. From the list of those designated for vaccination to issuing an electronic certificate, the entire process is meant to be digital and managed using the Co-Win app.

Katharina Bucholz has written an article for Statista based on data from data analytic company Affinity, stating that the US and India have the two largest capacities to manufacture Covid-19 vaccines till the end of 2021. The US can produce almost 4.7 billion doses, and India can deliver more than 3 billion doses this year.

The largest vaccine manufacturer globally is the Serum Institute of India, which produced 1.5 billion doses in 2015. SII has significantly enhanced its capabilities in the past pandemic year, while some expansion is still underway and likely to be completed in the current year.

The Serum Institute of India plans to produce 1 billion doses of the Oxford-AstraZeneca vaccine, which was rolled out on Tuesday with vaccinations to start by Saturday 16 January 2020. India’s domestically developed vaccine, Covaxin from Bharat Biotech, is also planning to roll out its first 12 million doses, although the stage III trials are not complete. Covaxin is also likely to be the first Indian manufactured Covid-19 vaccine exported. Bharat Biotech has already signed a deal with Precisa Medicamentos to supply the Covid-19 vaccine candidate to Brazil.

India has several other vaccine manufacturers and a more robust cold chain than many observers are aware of. Its pharma industry is well known for ethically supplying vaccines and treatment drugs to emerging countries at affordable prices.

The Covid-19 pandemic led to the country-wide lockdown on 25 March 2020. It will be two years tomorrow as I write this. What have we learned in this time? Maybe the meaning of resilience since small companies like us have had to rely on our resources and the forbearance of our employees as we have struggled to produce our trade platforms.

The print and packaging industries have been fortunate, although the commercial printing industry is still to recover. We have learned more about the digital transformation that affects commercial printing and packaging. Ultimately digital will help print grow in a country where we are still far behind in our paper and print consumption and where digital is a leapfrog technology that will only increase the demand for print in the foreseeable future.

Web analytics show that we now have readership in North America and Europe amongst the 90 countries where our five platforms reach. Our traffic which more than doubled in 2020, has at times gone up by another 50% in 2021. And advertising which had fallen to pieces in 2020 and 2021, has started its return since January 2022.

As the economy approaches real growth with unevenness and shortages a given, we are looking forward to the PrintPack India exhibition in Greater Noida. We are again appointed to produce the Show Daily on all five days of the show from 26 to 30 May 2022.

It is the right time to support our high-impact reporting and authoritative and technical information with some of the best correspondents in the industry. Readers can power Indian Printer and Publisher’s balanced industry journalism and help sustain us by subscribing.

– Naresh Khanna

Subscribe Now


Please enter your comment!
Please enter your name here